SB
ELV icon

Strategic Blueprint’s Elevance Health ELV Stock Holding History

Strategic Blueprint’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+627
New +$233K 0.01% 623
2026
Q1 		– Sell
-608
Closed -$213K – 660
2025
Q4 		$213K Sell
608
-81
-12% -$27.4K 0.01% 616
2025
Q3 		$223K Buy
+689
New +$214K 0.01% 676
2025
Q2 		– Sell
-460
Closed -$200K – 692
2025
Q1 		$200K Buy
+460
New +$185K 0.01% 656
2024
Q4 		– Sell
-560
Closed -$291K – 671
2024
Q3 		$291K Buy
560
+18
+3% +$9.62K 0.02% 519
2024
Q2 		$294K Buy
542
+32
+6% +$16.9K 0.02% 499
2024
Q1 		$264K Sell
510
-91
-15% -$45.3K 0.02% 518
2023
Q4 		$283K Sell
601
-5
-0.8% -$2.31K 0.02% 471
2023
Q3 		$264K Sell
606
-29
-5% -$13.2K 0.02% 449
2023
Q2 		$282K Sell
635
-75
-11% -$34.6K 0.03% 439
2023
Q1 		$327K Sell
710
-90
-11% -$42.8K 0.03% 388
2022
Q4 		$411K Buy
800
+6
+0.8% +$3.05K 0.05% 333
2022
Q3 		$361K Sell
794
-74
-9% -$35.4K 0.04% 330
2022
Q2 		$419K Buy
868
+4
+0.5% +$1.98K 0.05% 311
2022
Q1 		$424K Sell
864
-16
-2% -$7.31K 0.05% 312
2021
Q4 		$408K Sell
880
-45
-5% -$18.9K 0.05% 309
2021
Q3 		$345K Buy
925
+526
+132% +$200K 0.05% 304
2021
Q2 		$152K Buy
+399
New +$152K 0.02% 418
2019
Q4 		– Sell
-304
Closed -$73K – 184
2019
Q3 		$73K Buy
+304
New +$83.3K 0.06% 126

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Strategic Blueprint's ELV Position: Q2 2026 in Review

Strategic Blueprint opened a new position in Elevance Health (ELV) in Q2 2026: 627 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #623 among its holdings. This is a return to the name: Strategic Blueprint previously reported a position in ELV as recently as Q4 2025.

Strategic Blueprint first reported a position in ELV in Q3 2019 and has held it in 19 quarters since. The position peaked at $424K in Q1 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Strategic Blueprint held 627 shares of Elevance Health worth $243K as of Q2 2026.
  • Elevance Health was a new Strategic Blueprint position in Q2 2026.
  • Elevance Health made up 0.01% of Strategic Blueprint's portfolio in Q2 2026, its #623 holding.
  • Strategic Blueprint first reported a position in Elevance Health in Q3 2019 and has held it in 19 quarters since.
  • Strategic Blueprint's Elevance Health position peaked at $424K in Q1 2022.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.